Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Tuberculosis in systemic connective tissue diseases].

N Filipović-Grcić1, Z Horvat, J Markeljević

  • 1Klinika za unutrasnje bolesti Rebro, KBC, Medicinski fakultet Sveucilista u Zagrebu.

Lijecnicki Vjesnik
|January 1, 1992
PubMed
Summary

Patients with connective tissue diseases (CTDs) undergoing immunosuppressive treatment are at high risk for developing tuberculosis (TB). This dangerous complication, often fatal, highlights the need for vigilant monitoring in immunocompromised individuals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Haptoglobin genotype 2-2 associated with atherosclerosis in patients with ischemic stroke.

Gene·2020
Same author

Serotonin transporter gene polymorphisms: Relation with platelet serotonin level in patients with primary Sjogren's syndrome.

Journal of neuroimmunology·2015
Same author

[Intermittent intravenous cyclophosphamide application in patients with systemic lupus erythematosus].

Lijecnicki vjesnik·2009
Same author

Current causes of death in systemic lupus erythematosus in Europe, 2000--2004: relation to disease activity and damage accrual.

Lupus·2007
Same author

Fine-needle aspiration cytology, salivary gland ultrasonography, and sialography in the evaluation of primary Sjögren's syndrome.

Scandinavian journal of rheumatology·2006
Same author

Salivary and serum interleukin 6 and basic fibroblast growth factor levels in patients with oral squamous cell carcinoma.

Minerva stomatologica·2005

Area of Science:

  • Rheumatology
  • Infectious Diseases
  • Immunology

Background:

  • Connective tissue diseases (CTDs) involve complex immunopathologic processes that compromise host resistance.
  • Treatments for CTDs often include glucocorticoids and immunosuppressive agents, further suppressing the immune system.

Observation:

  • Six female patients with underlying CTDs (systemic lupus erythematosus, rheumatoid arthritis, polymyositis) developed tuberculosis during treatment.
  • Tuberculosis is frequently observed in patients with chronic, debilitating illnesses and diminished immunity.

Findings:

  • The immunopathologic nature of CTDs and their treatments significantly decrease the body's ability to fight infections like tuberculosis.
  • Tuberculosis presents as a severe and frequently fatal complication in the context of CTD management.

Related Experiment Videos

Implications:

  • Increased awareness and proactive screening for tuberculosis are crucial in patients with CTDs receiving immunosuppressive therapy.
  • Understanding the interplay between CTDs, immunosuppression, and infection risk is vital for improving patient outcomes.
  • This highlights the need for careful risk-benefit assessment when initiating and managing immunosuppressive treatments for CTDs.